Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism

Author： Cusack B. Gambliel H. Musser B. Hadjokas N. Shadle S. Charlier H. Olson R.

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.58, Iss.4, 2006-10, pp. : 517-526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Dexrazoxane use in the prevention of anthracycline extravasation injury

By Hasinoff Brian B

Future Oncology, Vol. 2, Iss. 1, 2006-02 ,pp. : 15-20

Future Medicine

Access to resources Recommend Favorite

Anthracycline-induced chronic cardiotoxicity and heart failure

By Appel Jon M. Nielsen Dorte Zerahn Bo Jensen Benny V. Skagen Knud

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 576-580

Informa Healthcare

Access to resources Recommend Favorite

Anthracycline cardiotoxicity and lymphoma

By Mayr David Fridrik Michael A.

memo - Magazine of European Medical Oncology, Vol. 7, Iss. 1, 2014-02 ,pp. : 43-46

Springer Publishing Company

Access to resources Recommend Favorite

Is the Fischer 344/CRJ rat a protein-knock-out model for dipeptidyl peptidase IV-mediated lung metastasis of breast cancer?

By Cheng Hung-Chi Abdel-Ghany Mossaad Zhang Shiying Pauli Bendicht

Clinical and Experimental Metastasis, Vol. 17, Iss. 7, 1999-09 ,pp. : 609-615

Springer Publishing Company

Access to resources Recommend Favorite

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review

By Swain S. Vici P.

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 1, 2004-01 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite